Related Experiment Videos
[Clofibrate banned - what now? (author's transl)].
MMW, Munchener Medizinische Wochenschrift
|April 13, 1979
Summary
For high lipid levels, Cedur, Lipanthyl, and Ronicol are recommended for reducing triglycerides and cholesterol. Skleronorm is effective for lowering cholesterol in hyperlipoproteinemia (HLP) Types IIa and IIb.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Metabolic Disorders
Context:
- Hyperlipoproteinemia (HLP) management
- Dyslipidemia treatment guidelines
- Drug efficacy in lipid reduction
Purpose:
- To recommend specific drugs for managing high triglyceride and cholesterol levels.
- To provide guidance on selecting appropriate lipid-lowering medications based on patient profiles and HLP types.
Summary:
- Recommends Cedur, Lipanthyl, and Ronicol for combined triglyceride and cholesterol reduction.
- Suggests Skleronorm for cholesterol reduction in HLP Types IIa and IIb.
- Advises Quantalan or Colestid for severe hypercholesterolemia and beta-sitosterin for milder forms.
- Cautionary note on clofibric acid preparations and essential phospholipids.
Impact:
- Informs clinical practice for dyslipidemia treatment.
- Aids in rational drug selection for hyperlipoproteinemia.
- Contributes to managing cardiovascular risk factors associated with lipid disorders.